News
| 3 min read
Study finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
| 2 min read
Eli Lilly's glucagon-like peptide-1 receptor agonist reduced A1C and body weight in adults with type 2 diabetes in Phase 3 SURPASS trials
| 2 min read
The collaboration plans to create stabilized live microbiota-based formulations for treating bacterial vaginosis
| 3 min read
Phase 1/2 trial will assess safety and efficacy of RECCE 327 against broad range of infectious diseases on chronic burn wounds
| 3 min read
Denali Therapeutics reports positive three-month data from Phase 1/2 study of DNL310 in patients with Hunter syndrome
| 3 min read
Newly launched company hits the ground running with $70M in financing and a collaboration with Takeda
| 2 min read
Researchers have identified the protein that converts amino acids into the enzyme cofactor cysteine tryptophylquinone
| 3 min read
Libtayo receives full approval in locally advanced BCC and accelerated approval in metastatic BCC
| 3 min read
Fungi in the gut help in the fight against dangerous blood-borne fungal infections
| 3 min read
Parexel, NeoGenomics unite to improve and accelerate clinical trials with real-world genomics data
| 3 min read
FDA approves Tepmetko as a once-daily oral MET inhibitor for NSCLC with METex14 skipping alterations
